About bluebird bio
At bluebird bio, the core of their identity is a relentless pursuit of curative gene therapies designed to offer new hope and more 'bluebird days' to patients and their families grappling with severe genetic diseases. For over a decade, since its founding in 2010, bluebird has been a trailblazer in the gene therapy landscape, initially as a scientific pioneer and now as a commercial leader. The company prides itself on an unparalleled track record of translating the complex promise of gene therapy from clinical studies into tangible, real-world treatments, highlighted by securing FDA approvals for three distinct therapies in less than two years. This commitment extends beyond the laboratory; bluebird bio is actively working to reshape the healthcare system by fostering access, transparency, and education, ensuring that the revolutionary potential of gene therapy can reach all who stand to benefit. Their approach is deeply rooted in a patient- and purpose-driven ethos, where every endeavor is guided by a passionate commitment to transforming lives.
The culture at bluebird bio is characterized by a unique blend of boldness, collaboration, and care. They actively cultivate an inclusive environment where honesty, respect, and a steadfast commitment to access, equity, and inclusivity are woven into the fabric of their daily operations. This 'flock' of dedicated individuals, or 'birds' as they affectionately call themselves, is united by a singular focus: to make a meaningful difference in the lives of patients. They embrace a 'never-give-up, little-but-mighty' attitude, constantly innovating and pushing the boundaries of science. The company custom designs each of its therapies to address the fundamental cause of a disease at the genetic level, leveraging its extensive ex-vivo gene therapy data set and industry-leading programs for conditions like sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. This dedication to scientific rigor is matched by a deep commitment to the patient communities they serve and a people-centric culture that attracts and nurtures a diverse and dedicated team, all striving to make hope a reality.
FAQs
- When was bluebird bio founded?
- bluebird bio was founded in 2010.
- Who is the CEO of bluebird bio?
- Andrew Obenshain is the CEO.
- What industries or markets does bluebird bio operate in?
- bluebird bio operates in the following markets: Gene Therapy, Biotechnology, Rare Diseases, Genetic Disorders, Healthcare, Life Sciences, Precision Medicine, Medical Research, FDA Regulated Therapies, and Pharmaceutical.
- How many employees does bluebird bio have?
- bluebird bio has 201-500 employees.
- Where does bluebird bio have employees?
- bluebird bio has employees in United States.
- Does bluebird bio support remote work or working from home?
- Yes, bluebird bio is a remote-friendly company.
- What employee benefits does bluebird bio offer?
- bluebird bio provides 26 benefits to their employees.
- Does bluebird bio offer a four-day work week?
- No, bluebird bio does not offer a four-day work week.
- What is bluebird bio's website?
- bluebird bio's website is bluebirdbio.com.
